(Press-News.org) Athens, Greece – 25 April 2024: Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).1
“Cholesterol-lowering drugs save lives and prevent heart attacks, and should be prescribed to all patients with coronary artery disease,” said study author Dr. Nina Johnston of Uppsala University, Sweden. “Unfortunately, our study shows that women are missing out on these essential medications.”
Patients with coronary artery disease, also called chronic coronary syndrome, require medication to alleviate symptoms and prevent heart attacks and death. ESC guidelines recommend statins for all patients to lower cholesterol levels in the blood.2 If levels are not sufficiently lowered with the maximum tolerated dose of statin, then patients should receive a statin plus another cholesterol-lowering drug called ezetimibe.2 The recommendations are the same for women and men.
Despite having the same recommendations for treatment and for target levels of low-density lipoprotein (LDL; “bad”) cholesterol, previous studies have shown that women are less likely to meet target levels than men.3 This study examined whether women and men receive the same treatments.
This was a retrospective observational study that included 1,037 men and 415 women with a chronic coronary syndrome diagnosed between 2012 and 2020, and who had never had a heart attack. The median age was 68 years in men and 70 years in women. Electronic health records were used to obtain data on cholesterol levels. Information on dispensed medications was obtained from the Swedish National Prescribed Drug Registry.
Participants were followed up for three years following their diagnosis. The researchers found that at the end of the third year of follow-up, just 54% of women were treated with cholesterol-lowering drugs compared with 74% of men. Additionally, 5% of women were treated with statin plus ezetimibe compared with 8% of men. Factors which may explain the observed sex differences are under further investigation by the research group.
The researchers also examined treatments and cholesterol levels of women and men diagnosed with a chronic coronary syndrome at different ages (less than 60, 60 to 69.9, 70-79.9, 80 years or older). In all age groups, prescription of cholesterol-lowering treatment was highest at diagnosis and declined over the following three years. This decline in treatment over time was steeper in women compared with men. For example, in patients under 60 years of age, 65% of women and 79% of men were treated with cholesterol-lowering treatment the week after diagnosis, compared with 52% of women and 78% of men three years later. Achievement of LDL cholesterol targets was also lower in women than men.
Dr. Johnston said: “Our findings should be a wake-up call about the undertreatment of women with heart disease. Equal prescribing practices are needed so that women receive all recommended therapies and are protected from adverse outcomes.”
Contrary to common belief, cardiovascular disease kills more women than men, accounting for 45% of all deaths in women which is more than all cancers combined in the 57 ESC member countries.4
Authors: ESC Press Office
Tel: +33 (0)489 872 075
Email: press@escardio.org
Follow us on X @ESCardioNews
Notes to editor
Funding: The study was co-funded by Amgen Europe and Uppsala Region.
Disclosures: Nina Johnston declares research projects partly financed by Amgen.
References and notes
1The abstract ‘Lipid-lowering treatment pattern in chronic coronary syndrome - lower proportion of treatment observed among women during 3 years of follow-up’ will be presented during the session ‘Lipid management in different populations’ which takes place on 25 April 2024 at 12:45 EEST on the Open stage.
2Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–477.
3Hambraeus K, Tydén P, Lindahl B. Time trends and gender differences in prevention guideline adherence and outcome after myocardial infarction: Data from the SWEDEHEART registry. Eur J Prev Cardiol. 2016;23:340–348.
4Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716–799.
About the European Association of Preventive Cardiology
The European Association of Preventive Cardiology (EAPC) is a branch of the ESC. Its mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
About ESC Preventive Cardiology #ESCPrev2024
ESC Preventive Cardiology, formerly EuroPrevent, is the leading international congress on preventive cardiology and the annual congress of the European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC).
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
Information for journalists about registration for ESC Preventive Cardiology 2024
ESC Preventive Cardiology 2024 takes place 25 to 27 April at the Megaron - Athens International Conference Centre, Greece. Explore the scientific programme.
Free registration applies to accredited press.
Credentials: A valid press card or appropriate letter of assignment with proof of three recent published articles. Read the ESC media and embargo policy.
The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid.
The ESC Press Office decision is final regarding all press registration requests.
END
Women with heart disease are less likely to receive life-saving drugs than men
2024-04-25
ELSE PRESS RELEASES FROM THIS DATE:
How electric vehicle drivers can escape range anxiety
2024-04-25
Two of the biggest challenges faced by new and potential electric vehicle (EV) drivers are range anxiety and speed of charging, but these shouldn’t have to be challenges at all. That is according to a study by Chalmers University of Technology, Sweden, and the University of Delaware, USA. Researchers discovered that a change in refuelling mindset, rather than improving the size or performance of the battery, could be the answer to these concerns.
The transition from filling up at a petrol station to recharging your electric vehicle in the most convenient location for you, requires a whole new way ...
How do birds flock? Researchers do the math to reveal previously unknown aerodynamic phenomenon
2024-04-25
In looking up at the sky during these early weeks of spring, you may very well see a flock of birds moving in unison as they migrate north. But how do these creatures fly in such a coordinated and seemingly effortless fashion?
Part of the answer lies in precise, and previously unknown, aerodynamic interactions, reports a team of mathematicians in a newly published study. Its breakthrough broadens our understanding of wildlife, including fish, who move in schools, and could have applications in transportation and energy.
“This area of research is important since animals are known to take advantage of the flows, such as of air or water, left by other members of ...
Experts call for global genetic warning system to combat the next pandemic and antimicrobial resistance
2024-04-25
The Covid-19 pandemic turned the world upside down. In fighting it, one of our most important weapons was genomic surveillance, based on whole genome sequencing, which collects all the genetic data of a given microorganism. This powerful technology tracked the spread and evolution of the virus, helping to guide public health responses and the development of vaccines and treatments.
But genomic surveillance could do much more to reduce the toll of disease and death worldwide than just protect us from Covid-19. Writing in Frontiers in Science, an international collective of clinical and public health microbiologists ...
Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds
2024-04-25
A new UCLA Health study found certain genetic variants could help explain how long-term pesticide exposure could increase the risk of Parkinson’s disease.
While decades of research have linked pesticide exposure and Parkinson’s disease risk, researchers have sought to explain why some individuals with high exposure develop the disease while others do not.
One longstanding hypothesis has been that susceptibility to the disease is a combination of both environmental and genetic factors.
The new study, published in the journal NPJ Parkinson’s Disease, used genetic data from nearly 800 Central Valley (California) residents with Parkinson’s ...
Deer are expanding north, and that’s not good for caribou
2024-04-25
As the climate changes, animals are doing what they can to adapt.
Researchers from UBC Okanagan—which includes partners from Biodiversity Pathways’ Wildlife Science Centre, the Alberta Biodiversity Monitoring Institute, the University of Alberta, and Environment and Climate Change Canada—wanted to evaluate why deer densities in the boreal forest are rapidly increasing.
Over the past century, white-tailed deer have greatly expanded their range in North America, explains Melanie Dickie, a doctoral student with UBC Okanagan’s Wildlife Restoration Ecology Lab.
In the boreal forest of Western Canada, ...
Puzzling link between depression and cardiovascular disease explained at last: they partly develop from the same gene module
2024-04-25
Depression and cardiovascular disease (CVD) are serious concerns for public health. Approximately 280 million people worldwide have depression, while 620 million people have CVD. It has been known since the 1990s that the two diseases are somehow related. For example, people with depression run a greater risk of CVD, while effective early treatment for depression cuts the risk of subsequently developing CVD by half. Conversely, people with CVD tend to have depression as well. For these reasons, the American Heart Association (AHA) advises to monitor teenagers with depression ...
Synthetic droplets cause a stir in the primordial soup
2024-04-25
Our bodies are made up of trillions of different cells, each fulfilling their own unique function to keep us alive.
How do cells move around inside these extremely complicated systems? How do they know where to go? And how did they get so complicated to begin with? Simple yet profound questions like these are at the heart of curiosity-driven basic research, which focuses on the fundamental principles of natural phenomena. An important example is the process by which cells or organisms move in response to chemical signals in their environment, also known as chemotaxis.
A constellation of researchers from three different research units at the Okinawa Institute of Science ...
Future parents more likely to get RSV vaccine when pregnant if aware that RSV can be a serious illness in infants
2024-04-25
A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.
Respiratory syncytial virus (RSV) is a leading cause of infection among infants, frequently resulting in hospital or intensive care admission. RSV infection severe enough to require hospitalization has been associated with long-term wheezing ...
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1
2024-04-25
Tumor-resident microbiota in breast cancer promotes both the initiation and progression of cancer. However, the potential of targeting microbiota to enhance the efficacy of breast cancer treatment has not been comprehensively explored. In this study, researchers analyzed the microbial composition within breast tumors and identified a notable enrichment of ETBF in patients who exhibited resistance to taxane-based neoadjuvant chemotherapy.
Key findings from the study include:
Even at low biomass levels, ETBF ...
The Lundquist Institute receives $2.6 million grant from U.S. Army Medical Research Acquisition Activity to develop wearable biosensors
2024-04-25
The U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded The Lundquist Institute (TLI) a four-year grant totaling $2,623,234. The research project is led by Dr. Harry Rossiter, an investigator at TLI and Professor at the David Geffen School of Medicine at UCLA. The project aims to develop wearable multiplex biosensors to monitor exacerbation risk in chronic obstructive pulmonary disease (COPD).
COPD affects approximately 16 million Americans and is the third leading cause of death globally. Acute exacerbations of COPD (AECOPD), typically caused by a lung infection, are associated ...